Avestar Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,520
Closed -$309K 451
2021
Q1
$309K Sell
4,520
-262
-5% -$17.1K 0.07% 243
2020
Q4
$316K Sell
4,782
-20
-0.4% -$1.18K 0.09% 198
2020
Q3
$250K Buy
4,802
+517
+12% +$26.5K 0.08% 181
2020
Q2
$212K Buy
+4,285
New +$231K 0.09% 165
2020
Q1
Sell
-4,335
Closed -$238K 167
2019
Q4
$238K Sell
4,335
-222
-5% -$12K 0.13% 141
2019
Q3
$229K Buy
4,557
+673
+17% +$33.8K 0.14% 134
2019
Q2
$177K Buy
3,884
+6
+0.2% +$291 0.11% 124
2019
Q1
$163K Sell
3,878
-337
-8% -$17.1K 0.11% 133
2018
Q4
$191K Sell
4,215
-1,223
-22% -$69.6K 0.13% 101
2018
Q3
$317K Buy
5,438
+826
+18% +$50.2K 0.18% 72
2018
Q2
$231K Sell
4,612
-734
-14% -$36.7K 0.15% 95
2018
Q1
$230K Buy
5,346
+798
+18% +$34.2K 0.15% 81
2017
Q4
$167K Buy
+4,548
New +$173K 0.12% 98

Other funds holding EHC

Avestar Capital's EHC Position: Q2 2021 in Review

Avestar Capital sold out of Encompass Health (EHC) in Q2 2021, closing a stake of 4,520 shares — an estimated $309K sold.

Avestar Capital first reported a position in EHC in Q4 2017 and held it in 13 quarters. The position peaked at $317K in Q3 2018. 414 funds tracked by Wall St. Rank hold EHC as of Q2 2021.

  • Avestar Capital reported no remaining Encompass Health position as of Q2 2021 after selling out during the quarter.
  • Avestar Capital sold 4,520 Encompass Health shares in Q2 2021, an estimated $309K.
  • Avestar Capital first reported a position in Encompass Health in Q4 2017 and held it in 13 quarters.
  • Avestar Capital's Encompass Health position peaked at $317K in Q3 2018.
  • 414 funds tracked by Wall St. Rank held Encompass Health as of Q2 2021.

Based on Avestar Capital's 13F filing for Q2 2021, filed 3 Aug 2021.